Published in Nature on January 09, 1997
Rapid methods for the analysis of immunoglobulin gene hypermutation: application to transgenic and gene targeted mice. Nucleic Acids Res (1997) 2.44
Immune regulation by the ST6Gal sialyltransferase. Proc Natl Acad Sci U S A (1998) 2.08
Paired immunoglobulin-like receptors and their MHC class I recognition. Immunology (2005) 2.07
Deficiency in CD22, a B cell-specific inhibitory receptor, is sufficient to predispose to development of high affinity autoantibodies. J Exp Med (1999) 1.83
Enhancement and suppression of signaling by the conserved tail of IgG memory-type B cell antigen receptors. J Exp Med (2007) 1.82
Initial clinical trial of epratuzumab (humanized anti-CD22 antibody) for immunotherapy of systemic lupus erythematosus. Arthritis Res Ther (2006) 1.82
Siglecs and immune regulation. Annu Rev Immunol (2012) 1.81
Calcium signalling and cell-fate choice in B cells. Nat Rev Immunol (2007) 1.64
Masking and unmasking of the sialic acid-binding lectin activity of CD22 (Siglec-2) on B lymphocytes. Proc Natl Acad Sci U S A (1998) 1.57
Type I IFN enhances follicular B cell contribution to the T cell-independent antibody response. J Exp Med (2010) 1.54
Inhibition of the B cell by CD22: a requirement for Lyn. J Exp Med (1998) 1.48
B cell antigen receptor signal strength and peripheral B cell development are regulated by a 9-O-acetyl sialic acid esterase. J Exp Med (2008) 1.45
Decoration of T-independent antigen with ligands for CD22 and Siglec-G can suppress immunity and induce B cell tolerance in vivo. J Exp Med (2009) 1.44
CD22: an inhibitory enigma. Immunology (2007) 1.43
A double-edged kinase Lyn: a positive and negative regulator for antigen receptor-mediated signals. J Exp Med (1998) 1.43
Btk dosage determines sensitivity to B cell antigen receptor cross-linking. Proc Natl Acad Sci U S A (1997) 1.42
Siglecs in the immune system. Immunology (2001) 1.42
CD5 negatively regulates the T-cell antigen receptor signal transduction pathway: involvement of SH2-containing phosphotyrosine phosphatase SHP-1. Mol Cell Biol (1999) 1.37
Masking of CD22 by cis ligands does not prevent redistribution of CD22 to sites of cell contact. Proc Natl Acad Sci U S A (2004) 1.35
The ligand-binding domain of CD22 is needed for inhibition of the B cell receptor signal, as demonstrated by a novel human CD22-specific inhibitor compound. J Exp Med (2002) 1.35
Sustained activation of Lyn tyrosine kinase in vivo leads to autoimmunity. J Exp Med (2002) 1.29
Siglecg limits the size of B1a B cell lineage by down-regulating NFkappaB activation. PLoS One (2007) 1.27
Developmental acquisition of the Lyn-CD22-SHP-1 inhibitory pathway promotes B cell tolerance. J Immunol (2009) 1.21
Identification of CD22 ligands on bone marrow sinusoidal endothelium implicated in CD22-dependent homing of recirculating B cells. J Exp Med (1999) 1.18
Comparison of predicted and actual consequences of missense mutations. Proc Natl Acad Sci U S A (2015) 1.17
CD22 EXON 12 deletion as a pathogenic mechanism of human B-precursor leukemia. Proc Natl Acad Sci U S A (2010) 1.15
ST6Gal-I restrains CD22-dependent antigen receptor endocytosis and Shp-1 recruitment in normal and pathogenic immune signaling. Mol Cell Biol (2006) 1.14
Esterases and autoimmunity: the sialic acid acetylesterase pathway and the regulation of peripheral B cell tolerance. Trends Immunol (2009) 1.12
Sialic acid binding domains of CD22 are required for negative regulation of B cell receptor signaling. J Exp Med (2002) 1.11
Siglecs as sensors of self in innate and adaptive immune responses. Ann N Y Acad Sci (2012) 1.08
Downregulated expression of SHP-1 in Burkitt lymphomas and germinal center B lymphocytes. J Exp Med (1997) 1.08
Regulation of B-cell entry into the cell cycle. Immunol Rev (2008) 1.06
Regulation of B cell functions by the sialic acid-binding receptors siglec-G and CD22. Front Immunol (2012) 1.04
Gene dose-dependent maturation and receptor editing of B cells expressing immunoglobulin (Ig)G1 or IgM/IgG1 tail antigen receptors. J Exp Med (2000) 1.04
B Lymphocyte signaling established by the CD19/CD22 loop regulates autoimmunity in the tight-skin mouse. Am J Pathol (2004) 1.02
A novel subset of murine B cells that expresses unmasked forms of CD22 is enriched in the bone marrow: implications for B-cell homing to the bone marrow. Immunology (2000) 0.97
Programmed cell death 1 suppresses B-1b cell expansion and long-lived IgG production in response to T cell-independent type 2 antigens. J Immunol (2011) 0.97
Copresentation of antigen and ligands of Siglec-G induces B cell tolerance independent of CD22. J Immunol (2013) 0.96
CD22 regulates adaptive and innate immune responses of B cells. J Innate Immun (2010) 0.96
Targeting CD22 as a strategy for treating systemic autoimmune diseases. Ther Clin Risk Manag (2007) 0.95
CD19 and CD22 expression reciprocally regulates tyrosine phosphorylation of Vav protein during B lymphocyte signaling. Proc Natl Acad Sci U S A (1997) 0.95
CD22 expression mediates the regulatory functions of peritoneal B-1a cells during the remission phase of contact hypersensitivity reactions. J Immunol (2010) 0.94
The pan-B cell marker CD22 is expressed on gastrointestinal eosinophils and negatively regulates tissue eosinophilia. J Immunol (2011) 0.94
Dendritic cell-dependent inhibition of B cell proliferation requires CD22. J Immunol (2008) 0.94
CD22 and Siglec-G in B cell function and tolerance. Trends Immunol (2012) 0.93
A Myc-regulated transcriptional network controls B-cell fate in response to BCR triggering. BMC Genomics (2009) 0.90
Nanoscale organization and dynamics of the siglec CD22 cooperate with the cytoskeleton in restraining BCR signalling. EMBO J (2015) 0.89
Treatment of systemic lupus erythematosus with epratuzumab. Br J Clin Pharmacol (2011) 0.89
A sensitized genetic system for the analysis of murine B lymphocyte signal transduction pathways dependent on Bruton's tyrosine kinase. Proc Natl Acad Sci U S A (2000) 0.87
CD22 ligand-binding and signaling domains reciprocally regulate B-cell Ca2+ signaling. Proc Natl Acad Sci U S A (2013) 0.86
CD22 is required for protection against West Nile virus Infection. J Virol (2013) 0.83
Division of labor during primary humoral immunity. Immunol Res (2013) 0.83
Carabin deficiency in B cells increases BCR-TLR9 costimulation-induced autoimmunity. EMBO Mol Med (2012) 0.82
Targeting B cells in systemic lupus erythematosus: not just déjà vu all over again. Arthritis Res Ther (2006) 0.82
Rethinking mechanisms of autoimmune pathogenesis. J Autoimmun (2013) 0.81
Cellular targeting in autoimmunity. Curr Allergy Asthma Rep (2012) 0.80
Pharmacokinetics and tolerability of human mouse chimeric anti-CD22 monoclonal antibody in Chinese patients with CD22-positive non-Hodgkin lymphoma. MAbs (2012) 0.79
Lysophosphatidic acid receptor 5 inhibits B cell antigen receptor signaling and antibody response. J Immunol (2014) 0.79
Biologic treatments for systemic rheumatic diseases. Oral Dis (2008) 0.79
B-cell homeostasis requires complementary CD22 and BLyS/BR3 survival signals. Int Immunol (2010) 0.78
Sialic acids and autoimmune disease. Immunol Rev (2016) 0.78
Intravital imaging of Ca(2+) signals in lymphocytes of Ca(2+) biosensor transgenic mice: indication of autoimmune diseases before the pathological onset. Sci Rep (2016) 0.77
CD22 is required for formation of memory B cell precursors within germinal centers. PLoS One (2017) 0.76
EndoU is a novel regulator of AICD during peripheral B cell selection. J Exp Med (2013) 0.76
Specificity and biologic activities of novel anti-membrane IgM antibodies. Oncotarget (2016) 0.75
Profile of epratuzumab and its potential in the treatment of systemic lupus erythematosus. Drug Des Devel Ther (2014) 0.75
An extracatalytic function of CD45 in B cells is mediated by CD22. Proc Natl Acad Sci U S A (2015) 0.75
Sialylation of N-glycans: mechanism, cellular compartmentalization and function. Histochem Cell Biol (2016) 0.75
Besides an ITIM/SHP-1-dependent pathway, CD22 collaborates with Grb2 and plasma membrane calcium-ATPase in an ITIM/SHP-1-independent pathway of attenuation of Ca2+i signal in B cells. Oncotarget (2016) 0.75
Targeting CD22 with the monoclonal antibody epratuzumab modulates human B-cell maturation and cytokine production in response to Toll-like receptor 7 (TLR7) and B-cell receptor (BCR) signaling. Arthritis Res Ther (2017) 0.75
Expansion of FasL-Expressing CD5(+) B Cells in Type 1 Diabetes Patients. Front Immunol (2017) 0.75
Augmented B lymphocyte response to antigen in the absence of antigen-induced B lymphocyte signaling in an IgG-transgenic mouse line. PLoS One (2010) 0.75
Infectivity and insertional mutagenesis of endogenous retrovirus in autoimmune NZB and B/W mice. J Gen Virol (2015) 0.75
CD72 negatively regulates B lymphocyte responses to the lupus-related endogenous toll-like receptor 7 ligand Sm/RNP. J Exp Med (2016) 0.75
A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(Kip1)-deficient mice. Cell (1996) 8.41
T-cell antigen CD28 mediates adhesion with B cells by interacting with activation antigen B7/BB-1. Proc Natl Acad Sci U S A (1990) 6.19
A lymphocyte-specific protein-tyrosine kinase gene is rearranged and overexpressed in the murine T cell lymphoma LSTRA. Cell (1985) 5.21
Subclass restriction of murine anti-carbohydrate antibodies. J Immunol (1978) 4.99
Interaction of the unique N-terminal region of tyrosine kinase p56lck with cytoplasmic domains of CD4 and CD8 is mediated by cysteine motifs. Cell (1990) 4.84
Early restriction of the human antibody repertoire. Science (1987) 3.90
Interaction of the IL-2 receptor with the src-family kinase p56lck: identification of novel intermolecular association. Science (1991) 3.84
Coexpression of the chemokines ELC and SLC by T zone stromal cells and deletion of the ELC gene in the plt/plt mouse. Proc Natl Acad Sci U S A (2000) 3.80
Activation of human B cells mediated through two distinct cell surface differentiation antigens, Bp35 and Bp50. Proc Natl Acad Sci U S A (1986) 3.68
A B-lymphocyte activation molecule related to the nerve growth factor receptor and induced by cytokines in carcinomas. EMBO J (1989) 3.62
Dissection of thymocyte signaling pathways by in vivo expression of pertussis toxin ADP-ribosyltransferase. EMBO J (1990) 3.62
Homing of a gamma delta thymocyte subset with homogeneous T-cell receptors to mucosal epithelia. Nature (1990) 3.55
Cloning of the murine thymic stromal lymphopoietin (TSLP) receptor: Formation of a functional heteromeric complex requires interleukin 7 receptor. J Exp Med (2000) 3.51
Cloning of a receptor subunit required for signaling by thymic stromal lymphopoietin. Nat Immunol (2000) 3.42
The CD28 ligand B7/BB1 provides costimulatory signal for alloactivation of CD4+ T cells. J Exp Med (1991) 3.35
Regulation of T cell receptor signaling by a src family protein-tyrosine kinase (p59fyn). Cell (1991) 3.30
Defective T cell receptor signaling in mice lacking the thymic isoform of p59fyn. Cell (1992) 3.17
ICAM-1 a ligand for LFA-1-dependent adhesion of B, T and myeloid cells. Nature (1988) 3.12
Caspase-mediated activation and induction of apoptosis by the mammalian Ste20-like kinase Mst1. EMBO J (1998) 3.03
Developmentally controlled expression of immunoglobulin VH genes. Science (1985) 2.96
B lymphoblast antigen (BB-1) expressed on Epstein-Barr virus-activated B cell blasts, B lymphoblastoid cell lines, and Burkitt's lymphomas. J Immunol (1982) 2.93
Macrophage-T cell interactions involving Listeria monocytogenes--role of the H-2 gene complex. J Immunol (1979) 2.93
Neoplastic transformation induced by an activated lymphocyte-specific protein tyrosine kinase (pp56lck). Mol Cell Biol (1988) 2.80
Activation of the Raf-1 kinase cascade by coumermycin-induced dimerization. Nature (1996) 2.79
A role for endogenous transforming growth factor beta 1 in Langerhans cell biology: the skin of transforming growth factor beta 1 null mice is devoid of epidermal Langerhans cells. J Exp Med (1996) 2.72
Thymic stromal lymphopoietin: a cytokine that promotes the development of IgM+ B cells in vitro and signals via a novel mechanism. J Immunol (1999) 2.57
Selective requirement for MAP kinase activation in thymocyte differentiation. Nature (1995) 2.53
Novel protein-tyrosine kinase gene (hck) preferentially expressed in cells of hematopoietic origin. Mol Cell Biol (1987) 2.52
The B7/BB1 antigen provides one of several costimulatory signals for the activation of CD4+ T lymphocytes by human blood dendritic cells in vitro. J Clin Invest (1992) 2.51
CD45 regulates signal transduction and lymphocyte activation by specific association with receptor molecules on T or B cells. Proc Natl Acad Sci U S A (1988) 2.46
Polygenic autoimmune traits: Lyn, CD22, and SHP-1 are limiting elements of a biochemical pathway regulating BCR signaling and selection. Immunity (1998) 2.42
Translational activation of the lck proto-oncogene. Nature (1988) 2.41
Expression of a novel form of the fyn proto-oncogene in hematopoietic cells. New Biol (1989) 2.34
Cross-linking CD40 on B cells rapidly activates nuclear factor-kappa B. J Immunol (1994) 2.31
CD40 stimulation provides an IFN-gamma-independent and IL-4-dependent differentiation signal directly to human B cells for IgE production. J Immunol (1991) 2.28
Production and characterization of cytotoxic Thy-1 antibody-secreting hybrid cell lines. Detection of T cell subsets. Eur J Immunol (1979) 2.20
Inhibition of T-cell receptor beta-chain gene rearrangement by overexpression of the non-receptor protein tyrosine kinase p56lck. EMBO J (1992) 2.12
Antibodies to common leukocyte antigen p220 influence human T cell proliferation by modifying IL 2 receptor expression. J Immunol (1985) 2.11
CD40 signaling activates CD11a/CD18 (LFA-1)-mediated adhesion in B cells. J Immunol (1991) 2.04
Involvement of p21ras distinguishes positive and negative selection in thymocytes. EMBO J (1995) 2.02
Induction of cytocidal macrophages after in vitro interactions between Listeria-immune T cells and macrophages--role of H-2. J Immunol (1979) 2.00
A dominant-negative transgene defines a role for p56lck in thymopoiesis. EMBO J (1993) 1.98
Thymic tumorigenesis induced by overexpression of p56lck. Proc Natl Acad Sci U S A (1991) 1.93
Inoculation of baboons and macaques with simian immunodeficiency virus/Mne, a primate lentivirus closely related to human immunodeficiency virus type 2. J Virol (1988) 1.91
Role of the Bp35 cell surface polypeptide in human B-cell activation. Proc Natl Acad Sci U S A (1985) 1.89
Soluble forms of CD40 inhibit biologic responses of human B cells. J Immunol (1992) 1.88
Some mismatch repair activities in Escherichia coli. Proc Natl Acad Sci U S A (1988) 1.87
CD40 molecules induce down-modulation and endocytosis of T cell surface T cell-B cell activating molecule/CD40-L. Potential role in regulating helper effector function. J Immunol (1994) 1.87
Positive and negative selection invoke distinct signaling pathways. J Exp Med (1996) 1.86
Evidence for selection of a population of multi-reactive B cells into the splenic marginal zone. Int Immunol (1997) 1.85
Fyn can partially substitute for Lck in T lymphocyte development. Immunity (1996) 1.85
Requirement for stat5 in thymic stromal lymphopoietin-mediated signal transduction. J Immunol (1999) 1.84
Leukemia of large granular lymphocytes: association with clonal chromosomal abnormalities and autoimmune neutropenia, thrombocytopenia, and hemolytic anemia. Ann Intern Med (1985) 1.83
Developmental regulation of lck gene expression in T lymphocytes. J Exp Med (1991) 1.82
Regulation of pp56lck during T-cell activation: functional implications for the src-like protein tyrosine kinases. EMBO J (1987) 1.80
Differential expression of ZAP-70 and Syk protein tyrosine kinases, and the role of this family of protein tyrosine kinases in TCR signaling. J Immunol (1994) 1.80
Impaired expansion of mouse B cell progenitors lacking Btk. Immunity (1995) 1.79
Functional dissection of the lck proximal promoter. Mol Cell Biol (1992) 1.78
Control of B cell development by Ras-mediated activation of Raf. EMBO J (1997) 1.76
Both phosphorylation and caspase-mediated cleavage contribute to regulation of the Ste20-like protein kinase Mst1 during CD95/Fas-induced apoptosis. J Biol Chem (2001) 1.76
CD19 monoclonal antibody HD37 inhibits anti-immunoglobulin-induced B cell activation and proliferation. J Immunol (1987) 1.76
Immunohistochemistry with enzyme labeled antibodies: a brief review. J Immunol Methods (1981) 1.75
Control of B cell production by the adaptor protein lnk. Definition Of a conserved family of signal-modulating proteins. Immunity (2000) 1.74
Disruption of thymocyte development and lymphomagenesis induced by SV40 T-antigen. Int Immunol (1990) 1.72
Syk and Bruton's tyrosine kinase are required for B cell antigen receptor-mediated activation of the kinase Akt. J Biol Chem (1999) 1.71
On the role of the platelet membrane skeleton in mediating signal transduction. Association of GP IIb-IIIa, pp60c-src, pp62c-yes, and the p21ras GTPase-activating protein with the membrane skeleton. J Biol Chem (1993) 1.71
Tyrosine phosphorylation of the Fc receptor gamma-chain in collagen-stimulated platelets. J Biol Chem (1996) 1.71
A role for pref-1 and HES-1 in thymocyte development. J Immunol (2000) 1.70
Secretion of mediators following T lymphocyte-macrophage interaction is regulated by the major histocompatibility complex. Proc Natl Acad Sci U S A (1977) 1.68
The role of CD40 and CD80 accessory cell molecules in dendritic cell-dependent HIV-1 infection. Immunity (1994) 1.67
Structure of the murine lck gene and its rearrangement in a murine lymphoma cell line. Mol Cell Biol (1988) 1.66
Differential increase of an alternatively polyadenylated mRNA species of murine CD40 upon B lymphocyte activation. J Immunol (1992) 1.66
CD150 association with either the SH2-containing inositol phosphatase or the SH2-containing protein tyrosine phosphatase is regulated by the adaptor protein SH2D1A. J Immunol (2001) 1.61
The CD11b promoter directs high-level expression of reporter genes in macrophages in transgenic mice. Blood (1995) 1.61
CD22 associates with the human surface IgM-B-cell antigen receptor complex. Proc Natl Acad Sci U S A (1993) 1.60
The generation of diversity in phosphorylcholine-binding antibodies. Adv Immunol (1984) 1.59
The CD20 (Bp35) antigen is involved in activation of B cells from the G0 to the G1 phase of the cell cycle. J Immunol (1985) 1.57
Expression of antigen-specific, major histocompatibility complex-restricted receptors by cortical and medullary thymocytes in situ. Cell (1985) 1.57
Molecular cloning of the human B cell CD20 receptor predicts a hydrophobic protein with multiple transmembrane domains. EMBO J (1988) 1.57
Cbl-mediated negative regulation of the Syk tyrosine kinase. A critical role for Cbl phosphotyrosine-binding domain binding to Syk phosphotyrosine 323. J Biol Chem (1998) 1.57
An activated lck transgene promotes thymocyte development in RAG-1 mutant mice. Immunity (1994) 1.55
Immunoglobulin subclass-specific immunodeficiency in mice with an X-linked B-lymphocyte defect. J Exp Med (1979) 1.54
OPG/FDCR-1, a TNF receptor family member, is expressed in lymphoid cells and is up-regulated by ligating CD40. J Immunol (1998) 1.54
Differential signaling by lymphocyte antigen receptors. Annu Rev Immunol (1997) 1.54
Structure and evolution of mammalian VH families. Int Immunol (1990) 1.53
Fluctuations of CD4+ T-cell subsets in remitting-relapsing multiple sclerosis. Ann Neurol (1988) 1.53
Polypeptides on human B lymphocytes associated with cell activation. Hum Immunol (1986) 1.50
Epithelial heterogeneity in the murine thymus: fucose-specific lectins bind medullary epithelial cells. J Immunol (1985) 1.49
The BB1 monoclonal antibody recognizes both cell surface CD74 (MHC class II-associated invariant chain) as well as B7-1 (CD80), resolving the question regarding a third CD28/CTLA-4 counterreceptor. J Immunol (1998) 1.49
Association of p56lck with IL-2 receptor beta chain is critical for the IL-2-induced activation of p56lck. EMBO J (1993) 1.48
T cell antigen receptor-mediated activation of the Ras/mitogen-activated protein kinase pathway controls interleukin 4 receptor function and type-2 helper T cell differentiation. Proc Natl Acad Sci U S A (1999) 1.46
Transgenic mice demonstrate that epithelial homing of gamma/delta T cells is determined by cell lineages independent of T cell receptor specificity. J Exp Med (1990) 1.45